Birgitte Volck
Equibles does not estimate personal net worth.
Get an email with a short summary when Ascendis Pharma A/S publishes a filing, an earnings call transcript or a press release.
Get ASND alertsAbout Birgitte Volck
Earlier roles on record: Board Member at Soleno Therapeutics Inc until May 18, 2026. Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Birgitte Volck resigned as member of the Company's board of directors, effective May 18, 2026. The same filing states: “The foregoing director and officer resignations were tendered in connection with the Merger and were not a result of any disagreement between the Company and such former directors and officers on any matter relating to the Company’s operations, policies or practices.” The proxy statement of Tectonic Therapeutic, Inc. reports total compensation of $2,397,398 for Birgitte Volck in fiscal 2020, including a base salary of $409,473. Ascendis Pharma A/S is classified in the Biotechnology industry within the Healthcare sector.
“each of Anish Bhatnagar, M.D., Mark Hahn, Matthew Pauls, Birgitte Volck, Andrew Sinclair and Dawn Bir resigned from his or her respective positions as a member of the Company's board of directors and all committees thereof effective as of the Effective Time.”
“The foregoing director and officer resignations were tendered in connection with the Merger and were not a result of any disagreement between the Company and such former directors and officers on any matter relating to the Company’s operations, policies or practices.”
Affiliation history
-
Ascendis Pharma A/S (ASND)
Source not stated
Current -
Soleno Therapeutics Inc
Board Member
Proxy statement
2019-01-01–2026-05-18
-
Tectonic Therapeutic, Inc. (TECX)
Proxy statement
Start not stated–2020-04-22
Last confirmed by a filing; no departure on record
Company network
Soleno Therapeutics Inc
Biotechnology · Healthcare
Board Member
2019-01-01–2026-05-18
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Tectonic Therapeutic, Inc. (TECX) | M.D., Ph.D. Former President of R&D | $409,473 | $2,397,398 |
Recent activity
-
Executive change Resigned: member of the Company's board of directors
“The foregoing director and officer resignations were tendered in connection with the Merger and were not a result of any disagreement between the Company and such former directors and officers on any matter relating to the Company’s operations, policies or practices.”
Soleno Therapeutics Inc